T

TLRY

TLRY

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
47%Neutral
Buy/Sell Ratio49% buys
BearishBullish
TLRY Live QuoteReal-time
$2.07
$0.85(-29.11%)1M
Day Range$2.04 – $2.24
Open$2.24
Previous Close$2.25
Volume7.76M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$332.52M
P/E Ratio (TTM)24.5
Forward P/E1000.0
EPS (TTM)$-1.41
Price to Book0.2
Dividend Yield0.65%
Beta (Volatility)2.06
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
52-Week RangeCurrent: $2.07 (0%)
Low: $2.04High: $15.70
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$5.72-96.2% upside

Insider Buys

7

$228K

Insider Sales

1

$233K

Total Volume

$461K

15 transactions

Net Activity

$5K

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
95CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Balanced trading volume with net neutral buying and selling activity.
  • •Cluster buying: 4 unique insiders purchased shares, showing strong alignment.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
  • •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys7 sells

$674.46B total

H
2

Hopkinson David G.

Dir

0 buys1 sells

$233K total

M
3

Merton Carl A

CFO

3 buys0 sells

$101K total

S
4

Simon Irwin D

Pres, CEO

1 buys0 sells

$100K total

G
5

Gendel Mitchell

Global GC

2 buys0 sells

$15K total

Trading History
TLRY insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Aug 6, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell124.9K$2500.00$312.21M

Aug 6, 2026

3 months ago

Gendel Mitchell

Global GC

General Counsel
Buy2.5K$4.43$11K

Aug 4, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell139.8K$10000.00$1.40B

Aug 4, 2026

3 months ago

Merton Carl A

CFO

CFO
Buy10.0K$4.62$46K

Aug 3, 2026

3 months ago

Faltischek Denise M

Chief Strategy Officer

C-Level
Buy2.5K$4.78$12K

Aug 3, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell141.3K$2500.00$353.21M

Apr 21, 2026

7 months ago

Hopkinson David G.

Dir

Director
Sell33.6K$6.94$233K

Apr 21, 2026

7 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell0$-33556.00$0

Jul 31, 2025

15 months ago

Gendel Mitchell

Global GC

General Counsel
Buy6.0K$0.58$3K

Jul 31, 2025

15 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell698.3K$6000.00$4.19B

Jul 30, 2025

15 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell3.94M$165000.00$650.37B

Jul 30, 2025

15 months ago

Simon Irwin D

Pres, CEO

CEO
Buy165.0K$0.61$100K

Jul 30, 2025

15 months ago

Merton Carl A

CFO

CFO
Buy33.5K$0.60$20K

Nov 15, 2024

24 months ago

Merton Carl A

CFO

CFO
Buy26.0K$1.36$35K

Nov 15, 2024

24 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell686.1K$26000.00$17.84B
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
TLRY Buy Conviction49%
Industry Rank#0 of 570
Volume Contribution0.0%
Total Industry Activity$16.44B

TLRY has an insider buy conviction of 49%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for TLRY

Over the last 90 days, corporate insiders at TLRY (TLRY) engaged in a total of 15 transactions reported via SEC Form 4 filings. Among these, 7 were open-market purchases and 1 were sales. The total volume of insider trading reached $461K.

The net insider activity for TLRY shows a net selling bias of $5K. This activity represents a 49% buy ratio, suggesting that insiders are currently neutral on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 3.94M shares valued at $650.37B on Jul 30, 2025.

Live Market News & Developments
Aggregated real-time headlines for TLRY (TLRY)
6 updates

Tilray Brands, Inc. (TLRY) Stock Price, News, Quote & History

Yahoo! Finance CanadaYesterday

Tilray Brands, Inc. (TLRY.TO) Stock Price, News, Quote & History

Yahoo! Finance CanadaYesterday

Tilray Brands (TLRY) Stock Forecast & Analyst Ratings

Moomoo23d ago

Tilray Brands Inc. stock falls Thursday, underperforms market

MarketWatch7h ago

Will Tilray stock avoid deeper losses amid strong downward price move?

Traders Union13h ago

Tilray Brands in downtrend: Bearish signals defy Wall Street's 'Buy' call

TradingView2d ago

FAQs About TLRY Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for TLRY.

Based on SEC Form 4 disclosures, the Insider Confidence Score for TLRY is currently 95/100, which reflects a strong accumulation bias. This calculation accounts for a total of 7 purchases and 1 sales by company executives over the last 90 days.

The CEO Conviction Index for TLRY is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.